Bg pattern

XARELTO 15 mg FILM-COATED TABLETS (100 tablets)

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use XARELTO 15 mg FILM-COATED TABLETS (100 tablets)

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Xarelto 15 mg film-coated tablets

Xarelto 20 mg film-coated tablets

rivaroxaban

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Xarelto and what is it used for
  2. What you need to know before you take Xarelto
  3. How to take Xarelto
  4. Possible side effects
  5. Storing Xarelto
  6. Contents of the pack and other information
Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

1. What is Xarelto and what is it used for

Xarelto contains the active substance rivaroxaban.

Xarelto is used in adults to:

  • prevent the formation of blood clots in the brain (stroke) or in other blood vessels of the body if you have a type of irregular heartbeat called non-valvular atrial fibrillation.
  • treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), and to prevent these blood clots from happening again in the veins and/or lungs.

Xarelto is used in children and adolescents under 18 years of age and with a body weight of 30 kg or more to:

  • treat blood clots and prevent them from happening again in the veins or in the blood vessels of the lungs, after initial treatment of at least 5 days with injectable medicines used to treat blood clots.

Xarelto belongs to a group of medicines called antithrombotic agents. It works by blocking a factor in the blood clotting process (factor Xa) and thus reduces the tendency of the blood to form clots.

2. What you need to know before you take Xarelto

Do not take Xarelto

  • if you are allergic to rivaroxaban or any of the other ingredients of this medicine (listed in section 6)
  • if you have bleeding problems
  • if you have a disease or condition that increases the risk of serious bleeding (e.g. stomach ulcer, recent injury or bleeding in the brain or a recent operation on the brain or eyes)
  • if you are taking medicines to prevent blood clots (e.g. warfarin, dabigatran, apixaban or heparin), except when switching from one anticoagulant treatment to another or when being treated with heparin through a venous or arterial catheter to prevent it from becoming blocked
  • if you have a liver disease that increases the risk of bleeding
  • if you are pregnant or breast-feeding.

Do not take Xarelto and inform your doctorif any of these apply to you.

Warnings and precautions

Consult your doctor or pharmacist before starting Xarelto.

Be careful with Xarelto

  • if you have an increased risk of bleeding, such as in the following situations:
    • severe kidney problems in adults and moderate or severe kidney problems in children and adolescents, as kidney function may affect the amount of medicine that works in the body
    • if you are taking other medicines to prevent blood clots (e.g. warfarin, dabigatran, apixaban or heparin), when switching to another anticoagulant treatment or while receiving heparin through a venous or arterial catheter to prevent it from becoming blocked (see section “Other medicines and Xarelto”)
    • bleeding disorders
    • very high blood pressure, not controlled by medical treatment
    • stomach or intestinal diseases that may cause bleeding, such as inflammation of the intestines or stomach, inflammation of the esophagus (throat), e.g. due to gastroesophageal reflux disease (a disease in which stomach acid rises up into the esophagus), or tumors in the stomach, intestines, genital or urinary tract
    • a problem in the blood vessels of the back of your eyes (retinopathy)
    • a lung disease in which the bronchi are dilated and filled with pus (bronchiectasis) or previous lung bleeding
  • if you have a heart valve replacement
  • if you know you have a disease called antiphospholipid syndrome (a disorder of the immune system that increases the risk of blood clots), inform your doctor so that they can decide if it is necessary to modify the treatment.
  • if your doctor determines that your blood pressure is unstable or if you are scheduled to receive another treatment or undergo surgery to remove a blood clot from your lungs.

Tell your doctor if you have any of these conditionsbefore taking Xarelto. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.

If you need to have surgery

  • It is very important to take Xarelto before and after surgery, exactly at the times indicated by your doctor.
  • If your operation requires the insertion of a catheter or injection into the spinal column (e.g. for epidural or spinal anesthesia, or pain relief):
    • It is very important to take Xarelto, before and after the injection or removal of the catheter, exactly at the times indicated by your doctor.
    • Tell your doctor immediately if you experience numbness or weakness in your legs or problems with your intestines or bladder at the end of anesthesia, as urgent attention is needed.

Children and adolescents

Xarelto tablets are not recommended in children with a body weight below 30 kg. There is not enough information on the use of Xarelto in children and adolescents for the indications in adults.

Other medicines and Xarelto

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines, including those obtained without a prescription.

  • If you are taking
    • any medicine for a fungal infection (e.g. fluconazole, itraconazole, voriconazole, posaconazole), unless it is only applied to the skin
    • ketoconazole tablets (used to treat Cushing's syndrome, in which the body produces too much cortisol)
    • any medicine for bacterial infections (e.g. clarithromycin, erythromycin)
    • any antiviral medicine for HIV/AIDS (e.g. ritonavir)
    • other medicines to reduce blood clotting (e.g. enoxaparin, clopidogrel or vitamin K antagonists, such as warfarin or acenocoumarol)
    • anti-inflammatory medicines and painkillers (e.g. naproxen or acetylsalicylic acid)
    • dronedarone, a medicine for the treatment of irregular heartbeat
    • certain medicines for the treatment of depression (selective serotonin reuptake inhibitors (SSRIs) or serotonin and norepinephrine reuptake inhibitors (SNRIs))

If any of these apply to you, tell your doctorbefore taking Xarelto, as the effect of Xarelto may be increased. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.

If your doctor considers that you have a higher risk of developing a stomach or intestinal ulcer, they may recommend that you also take a preventive treatment.

  • If you are taking
    • any medicine for the treatment of epilepsy (phenytoin, carbamazepine, phenobarbital)
    • St. John's Wort (Hypericum perforatum), a herbal medicine for the treatment of depression
    • rifampicin, an antibiotic.

If any of these apply to you, tell your doctorbefore taking Xarelto, as the effect of Xarelto may be reduced. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.

Pregnancy and breast-feeding

Do not take Xarelto if you are pregnant or breast-feeding. If there is a possibility that you may become pregnant, use a reliable contraceptive while taking Xarelto. If you become pregnant while taking this medicine, tell your doctor immediately, who will decide how you should be treated.

Driving and using machines

Xarelto may cause dizziness (a common side effect) or fainting (an uncommon side effect) (see section 4 “Possible side effects”). You should not drive, ride a bicycle or use tools or machines if you are affected by these symptoms.

Xarelto contains lactose and sodium

If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially “sodium-free”.

3. How to take Xarelto

Follow exactly the instructions of your doctor. If you are unsure, consult your doctor or pharmacist again.

You should take Xarelto with food.

Swallow the tablets, preferably with water.

If you have difficulty swallowing the tablet whole, consult your doctor about other ways to take Xarelto. The tablet can be crushed and mixed with water or apple puree, immediately before taking it. Then take food.

If necessary, your doctor may also administer the crushed Xarelto tablet through a gastric tube.

What dose to take

  • Adults
    • to prevent the formation of blood clots in the brain (stroke) or in other blood vessels of the body

The recommended dose is one Xarelto 20 mg tablet once a day.

If you have kidney problems, the dose may be reduced to one Xarelto 15 mg tablet once a day.

If you need to undergo a procedure to treat blocked blood vessels in your heart (called percutaneous coronary intervention - PCI with stent insertion), there is limited evidence to reduce the dose to one Xarelto 15 mg tablet once a day (or to one Xarelto 10 mg tablet once a day in case your kidneys do not work properly) in addition to an antiplatelet medicine like clopidogrel.

  • to treat blood clots in the veins of the legs and in the blood vessels of the lungs, and to prevent them from happening again.

The recommended dose is one Xarelto 15 mg tablet twice a day for the first 3 weeks. For treatment after 3 weeks, the recommended dose is one Xarelto 20 mg tablet once a day.

After at least 6 months of treatment for blood clots, your doctor may decide to continue treatment with one Xarelto 10 mg tablet once a day or one Xarelto 20 mg tablet once a day.

If you have kidney problems and are taking one Xarelto 20 mg tablet once a day, your doctor may decide to reduce the treatment dose to one Xarelto 15 mg tablet once a day after 3 weeks if the risk of bleeding is higher than the risk of having another blood clot.

-

The dose of Xarelto depends on body weight and will be calculated by your doctor.

  • The recommended dose for children and adolescents with a body weight of between 30 kg and less than 50 kgis one Xarelto 15 mgtablet once a day.
  • The recommended dose for children and adolescents with a body weight of 50 kgor more is one Xarelto 20 mgtablet once a day.

Take each dose of Xarelto with a drink (e.g. water or juice) during a meal. Take the tablets every day at approximately the same time. Consider setting an alarm to remind you. For parents or caregivers: observe the child to ensure they take the entire dose.

Since the dose of Xarelto is based on body weight, it is important to attend scheduled visits with your doctor, as it may be necessary to adjust the dose as weight changes.

Never adjust the dose of Xarelto on your own. Your doctor will adjust the dose if necessary.

Do not divide the tablet to try to obtain a fraction of the tablet dose. If a smaller dose is required, please use the alternative Xarelto granule presentation for oral suspension.

In children and adolescents who cannot swallow whole tablets, please use Xarelto granules for oral suspension.

If the oral suspension is not available, you can crush the Xarelto tablet and mix it with water or apple puree immediately before taking it. Take some food after taking this mixture. If necessary, your doctor may also administer the crushed Xarelto tablet through a gastric tube.

If you spit out the dose or vomit

  • less than 30 minutes after taking Xarelto, take a new dose.
  • more than 30 minutes after taking Xarelto, do nottake a new dose. In this case, take the next dose of Xarelto at the usual time.

Call your doctor if you spit out the dose or vomit repeatedly after taking Xarelto.

When to take Xarelto

Take the tablets every day, until your doctor tells you to stop.

Try to take the tablets at the same time every day to remember when to take them. Your doctor will decide how long you should continue taking the treatment.

To prevent blood clots in the brain (stroke) or in other blood vessels: If it is necessary to normalize your heartbeat through a procedure called cardioversion, take Xarelto at the times indicated by your doctor.

If you forget to take Xarelto

  • Adults, children and adolescents:

If you are taking one 20 mg or one 15 mg tablet oncea day, and you miss a dose, take it as soon as you remember. Do not take more than one tablet in one day to make up for a missed dose. Take the next tablet the next day and then continue taking one tablet every day.

  • Adults:

If you are taking one 15 mg tablet twicea day, and you miss a dose, take it as soon as you remember. Do not take more than two 15 mg tablets in one day. If you miss a dose, you can take two 15 mg tablets at the same time, for a total of two tablets (30 mg) in one day. The next day, you should continue taking one 15 mg tablet twice a day.

If you take more Xarelto than you should

Call your doctor immediately if you have taken too many Xarelto tablets. Taking too much Xarelto increases the risk of bleeding.

If you stop taking Xarelto

Do not stop taking Xarelto without first consulting your doctor, as Xarelto treats and prevents serious conditions.

If you have any other questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, Xarelto can cause side effects, although not everybody gets them.

Like other medicines to reduce blood clotting, Xarelto can cause bleeding that can be life-threatening. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be visible.

Tell your doctor immediately if you experience any of the following symptoms:

  • Signs of bleeding
  • bleeding in the brain or inside the skull (symptoms may include headache, weakness on one side, vomiting, seizures, decreased level of consciousness and stiff neck. This is a serious medical emergency. Go to the doctor immediately!)
  • prolonged or excessive bleeding
  • extreme weakness, tiredness, paleness, dizziness, headache, unexplained swelling, difficulty breathing, chest pain or angina, which may be signs of bleeding.

Your doctor may decide to keep you under closer observation or change your treatment.

?

  • severe skin reactions that spread, blisters or lesions on the mucous membranes, e.g. in the mouth or eyes (Stevens-Johnson syndrome/toxic epidermal necrolysis).
  • drug reactions that cause rash, fever, inflammation of internal organs, blood abnormalities and systemic disease (DRESS syndrome).

The frequency of these side effects is very rare (up to 1 in 10,000 people).

Warning

  • swelling of the face, lips, mouth, tongue or throat; difficulty swallowing; hives and difficulty breathing; sudden drop in blood pressure.

The frequencies of severe allergic reactions are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).

General list of possible adverse effects found in adults, children, and adolescents

Frequent(may affect up to 1 in 10 people)

  • decrease in red blood cells that can cause paleness and weakness or difficulty breathing
  • bleeding from the stomach or intestine, urogenital hemorrhage (including blood in the urine and heavy menstrual bleeding), nasal bleeding, gum bleeding
  • bleeding in the eye (including bleeding in the white part of the eye)
  • bleeding into a tissue or cavity of the body (hematoma, bruising)
  • coughing up blood
  • bleeding from the skin or under the skin
  • bleeding after surgery
  • oozing of blood or fluid from a surgical wound
  • swelling of the limbs
  • pain in the limbs
  • alteration of kidney function (may be seen in tests performed by the doctor)
  • fever
  • stomach pain, indigestion, nausea or feeling of nausea, constipation, diarrhea
  • low blood pressure (symptoms may be feeling of dizziness or fainting when standing up)
  • general decrease in strength and energy (weakness, fatigue), headache, dizziness,
  • rash, itching of the skin
  • blood tests may show an increase in some liver enzymes

Uncommon(may affect up to 1 in 100 people)

  • bleeding in the brain or inside the skull (see above, signs of bleeding)
  • bleeding in a joint, causing pain and swelling
  • thrombocytopenia (low platelet count, cells that help blood clotting)
  • allergic reaction, including skin allergic reaction
  • alteration of liver function (may be seen in tests performed by the doctor)
  • blood tests may show an increase in bilirubin, some pancreatic or liver enzymes, or platelet count
  • fainting
  • feeling of discomfort
  • increased heart rate
  • dry mouth
  • hives

Rare(may affect up to 1 in 1,000 people)

  • bleeding in a muscle
  • cholestasis (decrease in bile flow), hepatitis, including traumatic hepatocellular injury (inflammation or liver damage)
  • yellowing of the skin and eyes (jaundice)
  • localized swelling
  • blood accumulation (hematoma) in the groin after a complication in cardiac surgery where a catheter is inserted into the leg artery (pseudoaneurysm)

Very rare(may affect up to 1 in 10,000 people)

  • accumulation of eosinophils, a type of granulocytic white blood cells that cause inflammation in the lung (eosinophilic pneumonia).

Frequency not known(frequency cannot be estimated from available data)

  • renal failure after severe bleeding.
  • bleeding in the kidney, sometimes with blood in the urine, which causes the kidneys to malfunction (anticoagulant-related nephropathy)
  • increase in pressure in the muscles of the legs or arms after bleeding, causing pain, swelling, altered sensitivity, numbness, or paralysis (compartment syndrome after bleeding)

Adverse effects in children and adolescents

In general, the adverse effects observed in children and adolescents treated with Xarelto were similar to those observed in adults and their severity was mainly mild to moderate.

Adverse effects that were more frequently observed in children and adolescents:

Very common(may affect more than 1 in 10 people)

  • headache
  • fever
  • nasal bleeding
  • vomiting

Frequent(may affect up to 1 in 10 people)

  • accelerated heartbeats
  • blood tests may show an increase in bilirubin (bile pigment)
  • thrombocytopenia (low platelet count, cells that help blood clotting)
  • heavy menstrual bleeding

Uncommon(may affect up to 1 in 100 people)

  • blood tests may show an increase in a subcategory of bilirubin (direct bilirubin, bile pigment)

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can contribute to providing more information on the safety of this medicinal product.

5. Storage of Xarelto

Keep this medicinal product out of the sight and reach of children.

Do not use this medicinal product after the expiry date stated on the packaging and on each blister or bottle after "EXP" or "CAD".

The expiry date is the last day of the month indicated.

No special storage conditions are required.

Crushed tablets

Crushed tablets are stable in water or apple sauce for up to 4 hours.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medicinal products. This will help protect the environment.

6. Package contents and additional information

Composition of Xarelto

  • The active substance is rivaroxaban. Each tablet contains 15 mg or 20 mg of rivaroxaban.
  • The other ingredients are:

Core of the tablet: microcrystalline cellulose, sodium croscarmellose, lactose monohydrate, hypromellose (2910), sodium lauryl sulfate, magnesium stearate. See section 2 "Xarelto contains lactose and sodium"

Coating of the tablet: macrogol (3350), hypromellose (2910), titanium dioxide (E 171), red iron oxide (E 172).

Appearance of the product and package contents

The Xarelto 15 mg film-coated tablets are round, red, biconvex, and have the Bayer cross engraved on one side and "15" and a triangle on the other.

They are packaged

  • in blisters, in packs of 10, 14, 28, 42, or 98 film-coated tablets, or
  • in unit-dose blisters, in packs of 10 x 1 or 100 x 1, or
  • in multiple packs containing 10 packs of 10 x 1 film-coated tablets, or
  • in bottles containing 100 film-coated tablets.

The Xarelto 20 mg film-coated tablets are round, brown-red, biconvex, and have the Bayer cross engraved on one side and "20" and a triangle on the other.

They are packaged

  • in blisters, in packs of 10, 14, 28, or 98 film-coated tablets, or
  • in unit-dose blisters, in packs of 10 x 1 or 100 x 1, or
  • in multiple packs containing 10 packs of 10 x 1 film-coated tablets, or
  • in bottles containing 100 film-coated tablets.

Not all pack sizes may be marketed.

Marketing authorisation holder

Bayer AG

51368 Leverkusen Germany

Manufacturer

The manufacturer can be identified by the batch number printed on the side flap of the pack and on each blister or bottle:

  • If the first and second characters are BX, the manufacturer is

Bayer AG

Kaiser-Wilhelm-Allee 51368 Leverkusen Germany

  • If the first and second characters are IT, the manufacturer is

Bayer HealthCare Manufacturing Srl.

Via delle Groane, 126 20024 Garbagnate Milanese Italy

  • If the first and second characters are BT, the manufacturer is

Bayer Bitterfeld GmbH

Ortsteil Greppin, Salegaster Chaussee 1 06803 Bitterfeld-Wolfen

Germany

For further information on this medicinal product, contact the local representative of the marketing authorisation holder:

Belgium / Belgium / Belgien

Bayer SA-NV

Tel: +32-(0)2-535 63 11

Lithuania

UAB Bayer

Tel: +370-5-233 68 68

Bulgaria

Bayer EOOD

Tel: +359-(0)2-424 72 80

Luxembourg / Luxemburg

Bayer SA-NV

Tel: +32-(0)2-535 63 11

Czech Republic

Bayer s.r.o.

Tel: +420-266 101 111

Hungary

Bayer Hungária KFT

Tel: +36-1-487 4100

Denmark

Bayer A/S

Tel: +45-45 235 000

Malta

Alfred Gera and Sons Ltd.

Tel: +356-21 44 62 05

Germany

Bayer Vital GmbH

Tel: +49-(0)214-30 513 48

Netherlands

Bayer B.V.

Tel: +31–(0)297-28 06 66

Estonia

Bayer OÜ

Tel: +372-655 85 65

Norway

Bayer AS

Tel: +47-23 13 05 00

Greece

Bayer Ελλάς ΑΒΕΕ

Tel: +30-210-618 75 00

Austria

Bayer Austria Ges. m. b. H.

Tel: +43-(0)1-711 460

Spain

Bayer Hispania S.L.

Tel: +34-93-495 65 00

Poland

Bayer Sp. z o.o.

Tel: +48-22-572 35 00

France

Bayer HealthCare

Tel (Green Number): +33-(0) 800 87 54 54

Portugal

Bayer Portugal, Lda.

Tel: +351-21-416 42 00

Croatia

Bayer d.o.o.

Tel: + 385-(0)1-6599 900

Romania

SC Bayer SRL

Tel: +40-(0)21-528 59 00

Ireland

Bayer Limited

Tel: +353 1 216 3300

Slovenia

Bayer d. o. o.

Tel: +386-(0)1-58 14 400

Iceland

Icepharma hf.

Tel: +354-540 80 00

Slovak Republic

Bayer, spol. s r.o.

Tel: +421-(0)2-59 21 31 11

Italy

Bayer S.p.A.

Tel: +39-02-3978 1

Finland

Bayer Oy

Tel: +358-(0)20-78521

Cyprus

NOVAGEM Limited

Tel: +357-22-48 38 58

Sweden

Bayer AB

Tel: +46-(0)8-580 223 00

Latvia

SIA Bayer

Tel: +371-67 84 55 63

United Kingdom

Bayer plc

Tel: +44-(0)118 206 3000

Date of last revision of this leaflet:

Detailed information on this medicinal product is available on the European Medicines Agency website http://www.ema.europa.eu.

Online doctors for XARELTO 15 mg FILM-COATED TABLETS (100 tablets)

Discuss questions about XARELTO 15 mg FILM-COATED TABLETS (100 tablets), including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for XARELTO 15 mg FILM-COATED TABLETS (100 tablets)?
XARELTO 15 mg FILM-COATED TABLETS (100 tablets) requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in XARELTO 15 mg FILM-COATED TABLETS (100 tablets)?
The active ingredient in XARELTO 15 mg FILM-COATED TABLETS (100 tablets) is rivaroxaban. This information helps identify medicines with the same composition but different brand names.
Who manufactures XARELTO 15 mg FILM-COATED TABLETS (100 tablets)?
XARELTO 15 mg FILM-COATED TABLETS (100 tablets) is manufactured by Bayer Ag. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of XARELTO 15 mg FILM-COATED TABLETS (100 tablets) online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether XARELTO 15 mg FILM-COATED TABLETS (100 tablets) is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to XARELTO 15 mg FILM-COATED TABLETS (100 tablets)?
Other medicines with the same active substance (rivaroxaban) include BLOMENSY 15 mg FILM-COATED TABLETS, BLOMENSY 20 mg FILM-COATED TABLETS, COAGUBAN 10 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media